Evidence map›Paper›PMID 40280597›Full record

ArticleAmerican journal of industrial medicine2025

Silicosarcoidosis: Histologic and Clinical Features of an Occupational Granulomatous Disease.

Jeremy T Hua, Carlyne D Cool, Einat Fireman Klein, Yochai Adir, Lukas J Lee, Lauren M Zell-Baran, Robert A Cohen, Richard C Kraus, E Brigitte Gottschall, Silpa D Krefft and 2 more

Abstract readMulticenter StudyCase Reports
In one paragraph

Article in American journal of industrial medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Systemic chronic beryllium disease: beyond lung disease.Occupational and environmental medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jeremy T HuaDivision of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, USA.ORCID 0000-0001-7096-7784
Carlyne D CoolDivision of Pathology, University of Colorado School of Medicine, Aurora, Colorado, USA.
Einat Fireman KleinPulmonary Division, Carmel Medical Center, Faculty of Medicine Technion Institute of Technology, Haifa, Israel.
Yochai AdirPulmonary Division, Carmel Medical Center, Faculty of Medicine Technion Institute of Technology, Haifa, Israel.
Lukas J LeeDepartment of Occupational Medicine, Tao-Yuan General Hospital, Ministry of Health and Welfare, Tao-Yuan, Taiwan.ORCID 0000-0003-1095-6877
Lauren M Zell-BaranDivision of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, USA.ORCID 0000-0002-4134-8789
Robert A CohenEnvironmental and Occupational Health Sciences, School of Public Health, University of Illinois Chicago, Chicago, Illinois, USA.ORCID 0000-0001-7141-8795
Richard C KrausDivision of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, USA.
E Brigitte GottschallDivision of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, USA.
Silpa D KrefftDivision of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, USA.
Charles Van HookDepartment of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Cecile S RoseDivision of Environmental and Occupational Health Sciences, National Jewish Health, Denver, Colorado, USA.

Funding

J.T.H. was supported by the Reuben M. Cherniack fellowship award at the National Jewish Health.
6 · The paper itself

Abstract

Sarcoidosis is a multisystem inflammatory disease of unknown etiology. Growing evidence indicates that occupational exposure to respirable crystalline silica (RCS) is associated with an increased incidence of sarcoidosis. Yet a diagnosis of sarcoidosis rarely prompts investigation to identify preventable exposures. We sought to elucidate features that identify this important clinical syndrome of silicosarcoidosis. We assembled a multinational case series of workers with sarcoidosis who also reported occupational RCS exposure. We characterized clinical and histopathologic findings using a standardized instrument. We also assessed lung specimens using a novel quantitative microscopy technique to measure birefringent dust density in silicosarcoidosis cases and compared them to control groups. We identified 35 silicosarcoidosis cases (97% male, mean age 48 years) from the United States, Israel, and Taiwan who reported 21 ± 9 years of RCS exposure. On histology scoring, 25/29 (86%) had granulomas and 17/18 (94%) with evaluable lung tissue had lymphocytic inflammation and/or lymphoid aggregates. Common lung interstitial findings included silicotic nodules (39%), mixed-dust macules/nodules (44%), and birefringent dust (50%). Quantitative birefringent dust density was significantly greater (p < 0.001) in silicosarcoidosis cases compared with healthy controls (147 ± 179 vs. 12 ± 9 particles/mm

Indexed as

Occupational DiseasesOccupational ExposureSarcoidosis, PulmonarySilicon DioxideSilicosisAdultDustFemaleHumansIsraelLungMaleMiddle AgedTaiwanUnited StatesDustSilicon Dioxideartificial stonedustengineered stonegranulomaslung pathologyminingoccupational medicinepneumoconiosissarcoidosissilicosis

Identifiers

PMID40280597
PMCPMC12070142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.